Skip to main content

Baker McKenzie has represented U.S. food giant Post Holdings on its $1.8 billion purchase of British cereal maker Weetabix from China’s Bright Food Group and an investment fund owned by Baring Private Equity Asia, which tapped Ropes & Gray and Linklaters for advice. 

London-headquartered Mills & Reeve is acting for Weetabix’s executive management team while Missouri-based Lewis Rice is serving as U.S. counsel for Post.   

According to a Reuters report, Post said the acquistion will help its current brands – which include Honey Bunches of Oats and Grape-Nuts – to grow overseas, while expanding the distribution of Weetabix and its natural baked goods brand, Barbara's, in North America. 

The sale comes just five years after private equity firm Lion Capital sold a 60 percent stake in Weetabix to state-owned Bright Food for 1.2 billion pounds.

Founded in 1932, Weetabix has struggled to grow significantly as cold cereals in Western markets face increasing competition from breakfast bars and Greek yogurt, and consumers become more concerned about the sugar content of their food, said Reuters.

Post has agreed in principle to set up a joint venture with Bright Food and Baring for Weetabix’s Chinese operations, which remain a minor part of the business. Though retail sales of cold cereals have nearly doubled over the past five years in China, it is still a relatively small category, as majority of locals prefer hot breakfasts, added Reuters.

Corporate partners Charles Whitefoord and Regine Corrado as well competition partner Bill Batchelor oversaw the transaction for Bakers.

Private equity partners Will Rosen and Peng Yu headed the Ropes team, together with antitrust partner Ruchit Patel. The Linklaters team was led by private equity partner Carlton Evans and senior consultant Richard Gu.

Corporate partner Anthony McGurk handled the deal for Mills & Reeve, while coporate partner Tom Zook and and transaction partner Alfred Ludwig took the lead for Lewis Rice. 

Related Articles

A&O Shearman、高赢助力中国生物医药公司普米斯9.5亿美元并购交易(ZH/EN)

近日,A&O Shearman作为BioNTech的法律顾问,为其收购中国生物医药公司普米斯提供法律服务;高赢国际律师事务所则为普米斯提供法律意见。

汉坤、方达、竞天公诚、凯易助力科创板首单“A收H”交易(ZH/EN)

科创板上市公司亚信安全完成香港联交所主板上市公司亚信科技的控制权收购。汉坤律师事务所在交易中为买方提供中国法律服务;方达律师事务所、凯易国际律师事务所则担任卖方法律顾问;竞天公诚律师事务所担任融资方渤海银行的法律顾问。

方达、苏利文、奋迅·贝克麦坚时助力中印26亿美元钢铁领域合资交易(ZH/EN)

中国民营钢铁公司中国东方集团宣布将与世界第二大钢铁公司、印度安赛乐米塔尔合作,共同在中国设立两家合营企业。方达律师事务所、美国苏利文·克伦威尔律师事务所作为中国东方集团的律师参与交易;奋迅·贝克麦坚时为安赛乐米塔尔提供法律意见。